Alex Guerry
Executive Summary
Chattem chairman and president died suddenly on May 23 at the age of 72. Guerry had served on the Chattem board of directors since 1955, and held the title of president since 1958 and chairman of the board since 1959. His son, Zan Guerry, holds the title of corporate exec VP and president-Chattem Consumer Products. The family has requested that contributions be made to the Alex Guerry Memorial Fund, Baylor School. P.O. Box 1337, Chattanooga, TN 37401. Alex Guerry held 18% of Chattem stock. The Guerry family, officer and directors of the company hold over 47% of Chattem stock.
You may also be interested in...
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.